Old Web
English
Sign In
Acemap
>
authorDetail
>
Ikumi Nakashima
Ikumi Nakashima
Insulin
Renal glucose reabsorption
SGLT2 Inhibitor
Glycated hemoglobin
Biochemistry
2
Papers
250
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats
2009
European Journal of Pharmacology
Yoshikazu Fujimori
Kenji Katsuno
Kazuma Ojima
Ikumi Nakashima
Shigeru Nakano
Yukiko Ishikawa-Takemura
Hiroshi Kusama
Masayuki Isaji
Show All
Source
Cite
Save
Citations (67)
Remogliflozin Etabonate, in a Novel Category of Selective Low-Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors, Exhibits Antidiabetic Efficacy in Rodent Models
2008
Journal of Pharmacology and Experimental Therapeutics
Yoshikazu Fujimori
Kenji Katsuno
Ikumi Nakashima
Yukiko Ishikawa-Takemura
Hideki Fujikura
Masayuki Isaji
Show All
Source
Cite
Save
Citations (183)
1